Takeshi Ashizawa
Papers
1
Total Citations
11
H-Index
1
About
Dr. Takeshi Ashizawa is a leading urologic oncologist whose research centers on optimizing health-related quality of life (HRQOL) outcomes following robot-assisted radical prostatectomy (RARP) for localized prostate cancer. His most cited work, a 2021 study with 11 citations, provides critical longitudinal data on HRQOL using the Expanded Prostate Cancer Index Composite (EPIC) in Japanese men. Dr. Ashizawa’s major contribution lies in demonstrating how nerve-sparing techniques during RARP significantly influence postoperative recovery, offering evidence-based guidance for surgical decision-making. By focusing on patient-reported outcomes, he bridges the gap between surgical precision and long-term well-being, a vital perspective for personalized cancer care. His research has shaped clinical protocols in Japan, emphasizing the importance of functional preservation alongside oncologic control. Dr. Ashizawa’s work is particularly impactful for urologists and researchers seeking to refine minimally invasive techniques while prioritizing patients’ quality of life. Through his rigorous analysis of HRQOL trajectories, he continues to advance the field of robotic urologic surgery, ensuring that patient-centered metrics remain central to prostate cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1